LAST MODIFIED: OCTOBER 28, 2022
Biora Therapeutics is committed to its website being designed, developed, and operated in conformance with generally recognized and accepted standards for website accessibility. While these standards may change over time, they are currently the World Wide Web Consortium’s Web Content Accessibility Guidelines 2.1 at Levels A and AA (WCAG 2.1), a set of guidelines adopted by a private group designed to maximize accessibility of web content.
MEASURES TAKEN TO MAKE THIS WEBSITE MORE ACCESSIBILE
To comply with accessibility standards, this site has been reviewed by software developers and remediated to meet the WCAG 2.1 standards, which cover a wide range of recommendations for making website content more accessible to all people. As accessibility standards continue to change, our efforts to improve online accessibility are ongoing.
Please note that our website may link to, or interface with, third-party websites that we do not control, and which may not meet WCAG 2.1 standards. Despite our best efforts to ensure accessibility of this website, there may be challenges due to technological limitations or technical errors. We are dedicated to continual improvement of accessibility features and appreciate user feedback.
If you encounter any difficulty in using this website, please notify us at firstname.lastname@example.org.